Search Results - "ASAI, Akira"

Refine Results
  1. 1

    Metabolic Syndrome and Sarcopenia by Nishikawa, Hiroki, Asai, Akira, Fukunishi, Shinya, Nishiguchi, Shuhei, Higuchi, Kazuhide

    Published in Nutrients (07-10-2021)
    “…Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of muscle mass is closely linked to insulin resistance (IR) and…”
    Get full text
    Journal Article
  2. 2

    Cancer Cachexia: Its Mechanism and Clinical Significance by Nishikawa, Hiroki, Goto, Masahiro, Fukunishi, Shinya, Asai, Akira, Nishiguchi, Shuhei, Higuchi, Kazuhide

    “…The term "cachexia" is derived from the Greek words kakos (bad) and hexis (habit). Cachexia is a malnutrition associated with chronic diseases such as cancer,…”
    Get full text
    Journal Article
  3. 3

    Pathophysiology and mechanisms of primary sarcopenia (Review) by Nishikawa, Hiroki, Fukunishi, Shinya, Asai, Akira, Yokohama, Keisuke, Nishiguchi, Shuhei, Higuchi, Kazuhide

    “…Aging causes skeletal muscle atrophy, and myofiber loss can be a critical component of this process. In 1989, Rosenberg emphasized the importance of the loss…”
    Get full text
    Journal Article
  4. 4

    Body Composition in Chronic Liver Disease by Nishikawa, Hiroki, Kim, Soo Ki, Asai, Akira

    “…Body composition has recently been attracting people's attention, not only from a cosmetic standpoint but also from the perspective of health and longevity…”
    Get full text
    Journal Article
  5. 5

    The Significance of Zinc in Patients with Chronic Liver Disease by Nishikawa, Hiroki, Asai, Akira, Fukunishi, Shinya

    Published in Nutrients (01-11-2022)
    “…Zinc is an essential trace element for the maintenance of life because it acts as a center of activity or cofactor for hundreds of enzymes. Zinc deficiency…”
    Get full text
    Journal Article
  6. 6

    Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis by Yasuoka, Hidetaka, Asai, Akira, Ohama, Hideko, Tsuchimoto, Yusuke, Fukunishi, Shinya, Higuchi, Kazuhide

    Published in Scientific reports (25-06-2020)
    “…Anti-programmed cell death-1 (PD-1) antibodies has been approved to treat HCC. Some PD-1 ligands (PD–L1 and PD–L2) negative tumors respond to treatment of…”
    Get full text
    Journal Article
  7. 7

    Selectively bred rodent models for studying the etiology of type 2 diabetes: Goto-Kakizaki rats and Oikawa-Nagao mice by Nagao, Mototsugu, Asai, Akira, Eliasson, Lena, Oikawa, Shinichi

    Published in Endocrine Journal (2023)
    “…Type 2 diabetes (T2D) is a polygenic disease and studies to understand the etiology of the disease have required selectively bred animal models with polygenic…”
    Get full text
    Journal Article
  8. 8

    Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa–Nagao Diabetes-Prone and Diabetes-Resistant mice by Asai, Akira, Nagao, Mototsugu, Hayakawa, Koji, Miyazawa, Teruo, Sugihara, Hitoshi, Oikawa, Shinichi

    Published in Diabetologia (01-09-2020)
    “…Aims/hypothesis Obesity caused by overeating plays a pivotal role in the development of type 2 diabetes. However, it remains poorly understood how individual…”
    Get full text
    Journal Article
  9. 9

    Sarcopenia, frailty and type 2 diabetes mellitus (Review) by Nishikawa, Hiroki, Fukunishi, Shinya, Asai, Akira, Yokohama, Keisuke, Ohama, Hideko, Nishiguchi, Shuhei, Higuchi, Kazuhide

    Published in Molecular medicine reports (01-12-2021)
    “…Skeletal muscle is the largest and most energy‑consuming organ in the human body, which plays an important role in energy metabolism and glucose uptake. There…”
    Get full text
    Journal Article
  10. 10

    The Impacts of Cholesterol, Oxysterols, and Cholesterol Lowering Dietary Compounds on the Immune System by Yanagisawa, Rintaro, He, Chaoqi, Asai, Akira, Hellwig, Michael, Henle, Thomas, Toda, Masako

    “…Cholesterol and its oxidized forms, oxysterols, are ingested from foods and are synthesized de novo. Cholesterol and oxysterols influence molecular and…”
    Get full text
    Journal Article
  11. 11

    Discovery of a New STAT3 Inhibitor Acting on the Linker Domain by Koseki, Tatsuya, Suehiro, Naoya, Masuda, Yoshiaki, Miyoshi, Nao, Muraoka, Daisuke, Ogo, Naohisa, Asai, Akira

    Published in Biological & pharmaceutical bulletin (01-05-2019)
    “…Signal transducer and activator of transcription 3 (STAT3) is a latent transcription factor that contributes to tumor cell growth and survival and is often…”
    Get full text
    Journal Article
  12. 12

    Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice by Matsui, Masahiro, Fukunishi, Shinya, Nakano, Takashi, Ueno, Takaaki, Higuchi, Kazuhide, Asai, Akira

    Published in mBio (31-08-2021)
    “…Nonalcoholic fatty liver disease (NAFLD), characterized by excessive fat deposition in the liver unrelated to alcohol consumption, is highly prevalent…”
    Get full text
    Journal Article
  13. 13

    Identification of serum and glucocorticoid-regulated kinase 1 as a regulator of signal transducer and activator of transcription 3 signaling by Araki, Toshihiro, Watanabe, Yuuki, Okada, Yusuke, Murakami, Hisashi, Ogo, Naohisa, Asai, Akira

    Published in Experimental cell research (15-04-2022)
    “…Signal transducer and activator of transcription 3 (STAT3) plays key roles in cancer cell proliferation, invasion, and immunosuppression. In many human cancer…”
    Get full text
    Journal Article
  14. 14

    Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines by Taniguchi, Keisuke, Konishi, Hiroaki, Yoshinaga, Akiko, Tsugane, Momomi, Takahashi, Hiroyuki, Nishisaka, Fukiko, Shishido, Yoshiyuki, Asai, Akira

    Published in Scientific reports (23-03-2021)
    “…Signal transducer and activator of transcription 3 (STAT3) plays a critical role in regulating cell growth, survival, and metastasis. STAT3 signaling is…”
    Get full text
    Journal Article
  15. 15

    Various effects of two types of kinesin-5 inhibitors on mitosis and cell proliferation by Sawada, Jun-ichi, Matsuno, Kenji, Ogo, Naohisa, Asai, Akira

    Published in Biochemical pharmacology (01-11-2021)
    “…[Display omitted] Kinesin-5 has received considerable attention as a new target for mitosis. Various small-molecule compounds targeting kinesin-5 have been…”
    Get full text
    Journal Article
  16. 16

    Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO‐1701 by Nishisaka, Fukiko, Taniguchi, Keisuke, Tsugane, Momomi, Hirata, Genya, Takagi, Akimitsu, Asakawa, Naoyuki, Kurita, Akinobu, Takahashi, Hiroyuki, Ogo, Naohisa, Shishido, Yoshiyuki, Asai, Akira

    Published in Cancer science (01-05-2020)
    “…The signal transducer and activator of transcription 3 (STAT3) signaling pathway is a key mediator of cancer cell proliferation, survival and invasion…”
    Get full text
    Journal Article
  17. 17

    Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation by Suzuki, Fujio, Loucas, Bradford D, Ito, Ichiaki, Asai, Akira, Suzuki, Sumihiro, Kobayashi, Makiko

    Published in The Journal of immunology (1950) (01-07-2018)
    “…Macrophages (Mϕ) with the M2b phenotype (Pheno2b-Mϕ) in bacterial translocation sites have been described as cells responsible for the increased susceptibility…”
    Get full text
    Journal Article
  18. 18

    Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice by Asai, Akira, Shuto, Yuki, Nagao, Mototsugu, Kawahara, Momoyo, Miyazawa, Teruo, Sugihara, Hitoshi, Oikawa, Shinichi

    Published in Journal of Atherosclerosis and Thrombosis (01-12-2019)
    “…Aim: Although metformin treatment has been reported to reduce the risk of cardiovascular events in patients with type 2 diabetes, the underlying mechanisms…”
    Get full text
    Journal Article
  19. 19

    Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B by Nishikawa, Tomohiro, Matsui, Masahiro, Onishi, Saori, Ushiro, Kosuke, Asai, Akira, Kim, Soo-Ki, Nishikawa, Hiroki

    “…We sought to determine the long-term outcomes of chronic hepatitis B (CHB) cases switching to tenofovir alafenamide (TAF, = 104, median age = 63.5 years). Data…”
    Get full text
    Journal Article
  20. 20

    Sarcopenia and Frailty in Liver Cirrhosis by Nishikawa, Hiroki, Fukunishi, Shinya, Asai, Akira, Nishiguchi, Shuhei, Higuchi, Kazuhide

    Published in Life (Basel, Switzerland) (27-04-2021)
    “…Skeletal muscle is the largest organ in the body, and skeletal muscle atrophy results from a shift in the balance of protein synthesis and degradation toward…”
    Get full text
    Journal Article